Page last updated: 2024-10-25

cypermethrin and Atherosclerotic Parkinsonism

cypermethrin has been researched along with Atherosclerotic Parkinsonism in 2 studies

cypermethrin : A carboxylic ester resulting from the formal condensation between 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid and the alcoholic hydroxy group of hydroxy(3-phenoxyphenyl)acetonitrile.
zeta-cypermethrin : A diastereoisomeric mixture comprising the isomeric pair (1R)-cis-(alphaS)- and (1S)-trans-(alphaR)-cypermethrin together with the isomeric pair (1S)-cis-(alphaS)- and (1S)-trans-(alphaS)-cypermethrin where the ratio between the isomeric pairs lies in the range 45:55 to 55:45.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Rajput, C1
Sarkar, A1
Singh, MP2
Tripathi, P1
Singh, A1
Agrawal, S1
Prakash, O1

Other Studies

2 other studies available for cypermethrin and Atherosclerotic Parkinsonism

ArticleYear
Involvement of Peroxiredoxin-3, Thioredoxin-2, and Protein Deglycase-1 in Cypermethrin-Induced Parkinsonism.
    Molecular neurobiology, 2021, Volume: 58, Issue:9

    Topics: Animals; Cell Line, Tumor; Humans; Male; Mitochondria; Oxidative Stress; Parkinson Disease, Secondar

2021
Cypermethrin alters the status of oxidative stress in the peripheral blood: relevance to Parkinsonism.
    Journal of physiology and biochemistry, 2014, Volume: 70, Issue:4

    Topics: Animals; Catalase; Corpus Striatum; Dopamine; Glutathione Transferase; Insecticides; Male; Minocycli

2014